i-SENS Inc (099190) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.004x

Based on the latest financial reports, i-SENS Inc (099190) has a cash flow conversion efficiency ratio of -0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.56 Billion ≈ $-1.06 Million USD) by net assets (₩356.49 Billion ≈ $241.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 099190 equity to assets ratio to measure how much of total assets are equity-financed.

i-SENS Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how i-SENS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check i-SENS Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

i-SENS Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of i-SENS Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Vizsla Royalties Corp.
V:VROY
-0.007x
POLARIS RENEWABLE ENERGY
F:N4T
N/A
Ram Essential Services Property Fund
AU:REP
0.018x
Alcatel Lucent Teletas Telekomunikasyon AS
IS:ALCTL
-0.122x
Sula Vineyards Limited
NSE:SULA
0.007x
Braemar Hotel & Resorts Inc
NYSE:BHR
0.044x
CERENO SCIENTIFIC AB B
F:4A1
-0.151x
Getty Images Holdings Inc.
NYSE:GETY
0.067x

Annual Cash Flow Conversion Efficiency for i-SENS Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of i-SENS Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 099190 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩338.32 Billion
≈ $229.28 Million
₩20.12 Billion
≈ $13.63 Million
0.059x -11.16%
2024-12-31 ₩342.98 Billion
≈ $232.43 Million
₩22.96 Billion
≈ $15.56 Million
0.067x +55.73%
2023-12-31 ₩303.49 Billion
≈ $205.67 Million
₩13.05 Billion
≈ $8.84 Million
0.043x +84.64%
2022-12-31 ₩285.81 Billion
≈ $193.69 Million
₩6.65 Billion
≈ $4.51 Million
0.023x -63.73%
2021-12-31 ₩268.33 Billion
≈ $181.84 Million
₩17.22 Billion
≈ $11.67 Million
0.064x -59.30%
2020-12-31 ₩219.49 Billion
≈ $148.75 Million
₩34.61 Billion
≈ $23.46 Million
0.158x -17.49%
2019-12-31 ₩198.56 Billion
≈ $134.56 Million
₩37.95 Billion
≈ $25.72 Million
0.191x +76.94%
2018-12-31 ₩180.93 Billion
≈ $122.61 Million
₩19.54 Billion
≈ $13.24 Million
0.108x -21.41%
2017-12-31 ₩162.80 Billion
≈ $110.32 Million
₩22.38 Billion
≈ $15.16 Million
0.137x +75.44%
2016-12-31 ₩149.67 Billion
≈ $101.43 Million
₩11.73 Billion
≈ $7.95 Million
0.078x -54.15%
2015-12-31 ₩132.02 Billion
≈ $89.47 Million
₩22.56 Billion
≈ $15.29 Million
0.171x +13.76%
2014-12-31 ₩118.81 Billion
≈ $80.51 Million
₩17.85 Billion
≈ $12.09 Million
0.150x -3.22%
2013-12-31 ₩104.32 Billion
≈ $70.70 Million
₩16.19 Billion
≈ $10.97 Million
0.155x +108.16%
2012-12-31 ₩68.44 Billion
≈ $46.38 Million
₩5.10 Billion
≈ $3.46 Million
0.075x --

About i-SENS Inc

KQ:099190 Korea Healthcare Equipment & Supplies
Market Cap
$155.93 Million
₩230.10 Billion KRW
Market Cap Rank
#17446 Global
#678 in Korea
Share Price
₩16750.00
Change (1 day)
+8.77%
52-Week Range
₩14690.00 - ₩27000.00
All Time High
₩38452.83
About

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more